The biosimilars market involves the development, production, and commercialization of biologic medical products that are highly similar to already approved reference biologics. These products are used in the treatment of various chronic and acute diseases, including cancer, autoimmune disorders, and other serious health conditions. Biosimilars offer comparable safety, efficacy, and quality to their reference counterparts, often at a reduced cost, making them an important component in the pharmaceutical industry.